Loading...
XNASBGM
Market cap61mUSD
Dec 24, Last price  
8.56USD
1D
1.06%
1Q
11.17%
IPO
58.23%
Name

Qilian International Holding Group Ltd

Chart & Performance

D1W1MN
XNAS:BGM chart
P/E
P/S
1.32
EPS
Div Yield, %
2.92%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
-1.60%
Revenues
46m
-28.35%
22,537,34550,369,01346,096,68450,033,20057,099,88464,855,02546,471,478
Net income
-8m
L
1,414,7665,169,5075,332,3185,063,7103,152,8681,076,693-7,780,620
CFO
312k
-97.53%
2,681,7604,446,318-580,1975,076,014345,03412,654,188312,209

Profile

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.
IPO date
Jan 12, 2021
Employees
345
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑092022‑092021‑092020‑092019‑092018‑092017‑09
Income
Revenues
46,471
-28.35%
64,855
13.58%
Cost of revenue
46,432
63,977
Unusual Expense (Income)
NOPBT
40
878
NOPBT Margin
0.09%
1.35%
Operating Taxes
219
194
Tax Rate
548.46%
22.14%
NOPAT
(179)
683
Net income
(7,781)
-822.64%
1,077
-65.85%
Dividends
(1,788)
Dividend yield
1.27%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
553
1,696
Long-term debt
49
169
Deferred revenue
222
310
Other long-term liabilities
(222)
286
Net debt
(22,423)
(32,542)
Cash flow
Cash from operating activities
312
12,654
CAPEX
(3,714)
(3,259)
Cash from investing activities
(4,686)
(3,259)
Cash from financing activities
(2,978)
(5,938)
FCF
1,567
9,731
Balance
Cash
22,419
14,319
Long term investments
606
20,088
Excess cash
20,702
31,164
Stockholders' equity
7,940
18,553
Invested Capital
37,287
37,960
ROIC
1.65%
ROCE
0.09%
1.56%
EV
Common stock shares outstanding
35,750
35,750
Price
3.94
-33.29%
5.90
-70.72%
Market cap
140,716
-33.29%
210,925
-70.72%
EV
119,852
180,294
EBITDA
1,183
2,125
EV/EBITDA
101.31
84.85
Interest
2,058
Interest/NOPBT
234.43%